| Company Name: | EDAP TMS S.A. ADR | | Ticker Symbol: | EDAP | | | WWW Address: | http://www.edaptechnomed.com | | CEO: | Marc Oczachowski | | No. of Employees: | 142 | | Common Issue Type: | AD | | Business Description: | The company develops, produces and markets minimally invasive medical devices, mainly for urological diseases.
|
| | | Industry Information: | HEALTH SERVICES - Medical Appliances & Equipment [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 3.3 |  0.01 | 2.41 | 3.88 | 3.32 | 3.39 | 3.26 | 38031 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 32.8 | 9.9 | 1.14 | 0.24 | 0.00 | 14.0 | 0.0 | 5.95 - 0.96 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 3.30 | $ | | PE Ratio - LTM | 14.0 | |
| Market Capitalisation | 32.8 | mil |
| Latest Shares Outstanding | 9.9 | mil |
| Earnings pS (EPS) | 0.24 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 225,669 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 0.0 | mil |
| Float as % of Shares Outstanding | 0.0 | % |
| Foreign Sales | 0 | mil |
| Domestic Sales | 0 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 0.00 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 0.0 | % |
| EBITDA Margin | 0.0 | % |
| Pre-Tax Profit Margin | 0.0 | % |
| Assets Turnover | 0.0 | % |
| Return on Assets (ROA) | 0.0 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | 0.0 | % |
| Current Ratio | 2.5 | |
| Leverage Ratio (Assets/Equity) | 2.8 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.95 | |
| LT Debt/Total Capital | 44.0 | % |
| Working Capital pS | 2.75 | $ |
| Cash pS | 0.66 | $ |
| Book-Value pS | 2.00 | $ |
| Tangible Book-Value pS | 1.64 | $ |
| Cash Flow pS | 0.47 | $ |
| Free Cash Flow pS | -0.45 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.65 | |
| Price/Tangible Book Ratio | 2.01 | |
| Price/Cash Flow | 7.0 | |
| Price/Free Cash Flow | -7.3 | |
| P/E as % of Industry Group | 48.0 | % |
| P/E as % of Sector Segment | 7.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.3 | 99 | 631 | 379 |
| 4 Weeks | 3.88 | 2.80 | 3.18 | 3.8 | 97 | 735 | 11,762 |
| 13 Weeks | 5.18 | 2.80 | 3.88 | -14.9 | 79 | 4,582 | 274,934 |
| 26 Weeks | 5.95 | 1.20 | 1.70 | 94.1 | 161 | 4,837 | 599,767 |
| 52 Weeks | 5.95 | 0.96 | 1.64 | 101.2 | 163 | 2,514 | 623,545 |
| YTD | 5.95 | 0.96 | - | 129.2 | 187 | 2,750 | 621,521 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 3.38 | 3.51 | 3.68 | 2.56 | 2.23 | 1.14 | 0.99 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 6.08 | 55.9 | 10.38 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 23.63 | NA | 56.74 |
| R&D | 15.38 | NA | 41.35 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -1.7 | 0.0 | -1.7 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 1.10 | 0.33 | 1.10 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 48.62 |
| Current Ratio | 2.5 |
| Quick Ratio (Acid Test) | 2.1 |
| Liquidity Ratio (Cash) | 1.04 |
| Receivables Turnover | 1.6 |
| Average Collection Period | 225 |
| Working Capital/Equity | 124.1 |
| Working Capital pS | 3.09 |
| Cash-Flow pS | 0.49 |
| Free Cash-Flow pS | -0.83 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 1.85 |
| Financial Leverage Ratio (Assets/Equity) | 2.6 |
| Debt Ratio | 60.8 |
| Total Debt/Equity (Gearing Ratio) | 0.75 |
| LT Debt/Equity | 0.60 |
| LT Debt/Capital Invested | 44.3 |
| LT Debt/Total Liabilities | 38.9 |
| Interest Cover | 1.8 |
| Interest/Capital Invested | 4.80 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 3.09 |
| Tobin's Q Ratio | 0.54 |
| Current P/E Ratio - LTM | 14.00 |
| Enterprise Value (EV)/EBITDA | -12.10 |
| Enterprise Value (EV)/Free Cash Flow | -5.55 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 2.01 |
| Price/Book Ratio - LTM | 1.65 |
| Price/Cash Flow Ratio | 7.0 |
| Price/Free Cash Flow Ratio - LTM | -7.3 |
| Price/Sales Ratio | 1.02 |
| P/E Ratio (1 month ago) - LTM | 15.1 |
| P/E Ratio (26 weeks ago) - LTM | 7.1 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 48.0 |
| P/E as % of Sector Segment | 7.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 14.1 |
| PER SHARE FIGURES |
| LT Debt pS | 1.50 |
| Current Liabilities pS | 2.10 |
| Tangible Book Value pS - LTM | 1.64 |
| Book Value pS - LTM | 2.00 |
| Capital Invested pS | 3.85 |
| Cash pS - LTM | 0.66 |
| Cash Flow pS - LTM | 0.47 |
| Free Cash Flow pS - LTM | -0.45 |
| Earnings pS (EPS) | 0.24 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -24.77 |
| Free Cash Flow Margin 5YEAR AVG | -11.94 |
| Net Profit Margin | 6.9 |
| Net Profit Margin - 5YEAR AVRG. | -8.9 |
| Equity Productivity | 1.34 |
| Return on Equity (ROE) | 9.3 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 0.84 |
| Return on Capital Invested (ROCI) | 5.8 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -8.6 |
| Assets Productivity | 0.50 |
| Return on Assets (ROA) | 3.6 |
| Return on Assets (ROA) - 5YEAR AVRG. | -5.4 |
| Gross Profit Margin | 0.0 |
| Gross Profit Margin - 5YEAR AVRG. | 46.2 |
| EBITDA Margin - LTM | 0.0 |
| EBIT Margin - LTM | 0.0 |
| Pre-Tax Profit Margin | 4.8 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -9.2 |
| Effective Tax Rate | -44.5 |
| Effective Tax Rate - 5YEAR AVRG. | -17.3 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 369 |
| Revenue per Employee | 225,669 |
| Net Income per Employee | 15,634 |
| Average Collection Period | 243 |
| Receivables Turnover | 1.6 |
| Day's Inventory Turnover Ratio | 126 |
| Inventory Turnover | 2.8 |
| Inventory/Sales | 17.5 |
| Accounts Payble/Sales | 26.23 |
| Assets/Revenue | 2.00 |
| Net Working Capital Turnover | 1.08 |
| Fixed Assets Turnover | 2.85 |
| Total Assets Turnover | 0.5 |
| Revenue per $ Cash | 1.67 |
| Revenue per $ Plant | 6.13 |
| Revenue per $ Common Equity | 1.34 |
| Revenue per $ Capital Invested | 0.84 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 41.4 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 40.3 |
| Research & Devlopment (R&D) as % of Revenue | 18.5 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 18.5 |
|
|  
|
| |
 |  |